Roth Capital Raises Price Target on Lannett (LCI) Following Acquisition of Kremers Urban Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion
September 2, 2015 4:30 PM EDTPHILADELPHIA, Pa., Sept. 2, 2015 /PRNewswire/ --
Transaction Highlights:
Substantially increases, diversifies revenue base with highly profitable specialty products Expands pipeline with exciting products Near-term growth potential with 11 product applications pending at the FDA, of which five include Paragraph IV certifications Provides medium and longer term growth potential with 17 product candidates in development, including eight controlled substances Adds development expertise in difficult to formulate generics, including various dosage forms Accretive to adjusted EPS in fiscal 2016 in the... More